经皮经胸栓塞治疗外周肺动脉假性动脉瘤所致大咯血
回顾性分析2014年1月至2019年11月27例因大咯血且CT血管造影证实肺动脉假性动脉瘤、接受直接经皮栓塞治疗的患者,共治疗29个假性动脉瘤,技术成功率93.1%、临床成功率88.9%,仅1例出现明显气胸,无其他主要并发症。
要点
- 肺动脉假性动脉瘤是罕见但可治疗的大咯血病因,CT血管造影可显示。
- 直接经皮栓塞技术成功率93.1%、临床成功率88.9%,主要并发症为1例明显气胸。
- 在血管内栓塞不可行或不实际时,经皮栓塞可作为替代选择。
关键影像表现/征象
- 最常见病因为结核(85.1%),最常见部位为双侧上叶(各占31%)。
- CT引导是最常用的影像引导方式(26/29)。
诊断标准与关键数值
- 技术成功率为93.1%,临床成功率为88.9%。
- N-丁基氰基丙烯酸酯(NBCA)胶混合物用于79.3%的假性动脉瘤,其余20.7%使用重组凝血酶。
临床应用与阅片要点
- CT血管造影阳性发现肺动脉假性动脉瘤可用于筛选适合直接经皮栓塞的患者。
- 直接经皮栓塞可作为血管内栓塞不可行或不实际时的替代选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Pulmonary artery pseudoaneurysms (PAPs) are rare, but important and treatable cause of massive haemoptysis. Minimal data exists on their interventional radiology management due to their rarity, especially direct percutaneous injection. Here, we report our experience of direct percutaneous management of such pseudoaneurysms.
METHODS: Data of patients presenting to our department from January 2014 to November 2019 was retrospectively analysed, who presented with massive haemoptysis, and CT angiography positive for pulmonary artery pseudoaneurysms. Only patients treated with direct percutaneous intervention were included. Twelve patients who were managed endovascularly were excluded from the study. Observations were tabulated under age, sex, underlying pathology, lobe involved, number and size of the pseudoaneurysm, imaging guidance and embolising agent. Technical and clinical success and complications were then analysed.
RESULTS: Twenty-nine pseudoaneurysms were treated in 27 patients with a mean age of 41.4 years. The most common underlying aetiology was tuberculosis (85.1%), with the most common location being bilateral upper lobes (31% each). CT guidance was the most frequently used imaging guidance (26/29). N-butyl cyanoacrylate (NBCA) glue mixture was used in 79.3% and reconstituted thrombin in the remaining 20.7% pseudoaneurysms. Complete technical and clinical success rates were 93.1% and 88.9% respectively. No major complications were seen except for development of significant pneumothorax in one patient.
CONCLUSION: Pulmonary pseudoaneurysms are rare but fatal cause for massive haemoptysis. Interventional radiology management via direct percutaneous embolisation is a safe and minimally invasive treatment measure in selective patients, with successful outcomes and minimal complication and recurrence rates.
KEY POINTS: • Pulmonary artery pseudoaneurysms are rare but important and treatable cause of massive haemoptysis. • This study shows the advantages of percutaneous management of these pseudoaneurysms as an alternate to endovascular embolisation, in case endovascular embolisation is not feasible or practical. • It is a safe and minimally invasive treatment, with technical success of 93.1% and clinical success of 88.9% in this study.
引用
- Lal A, Bansal A, Chaluvashetty SB, et al. Percutaneous transthoracic embolisation for massive haemoptysis secondary to peripheral pulmonary artery pseudoaneurysms. Eur Radiol. 2020. PMID: 33011878. doi:10.1007/s00330-020-07348-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。